NCT05272917

Brief Summary

Cancer patients are at high risk for undernutrition. A study with head and neck cancer patients showed that 50% suffered from undernutrition (Prevost et al., 2014). Sensory alterations may also involve sensory changes from the physiological structures of the mouth or neural pathways and hedonic changes, i.e., although food may taste the same as usual, that taste is no longer judged as pleasant. These changes lead to an aversion to food and a decrease in the pleasure of eating (Bernhardson et al., 2009). Despite the large number of published studies on taste and smell alterations in diverse cancer populations, few have examined other dimensions of oral sensory alterations. Studies focusing on somesthesia have mostly been conducted in the area of oral physiology or stomatology in relation to oral pain and rehabilitation (Howes, Wongsriruksa, Laughlin, Witchel, \& Miodownik, 2014). Regarding food perception, somesthesia provides information about both texture, temperature, and trigeminal sensations. These sensations are detected by mechanical, thermal, nociceptive receptors present throughout the oral epithelium (Simons \& Carstens, 2008). In addition to taste and smell, food perception is influenced by oral somatosensation and studies have demonstrated an interrelated relationship between these oral sensations (Spence, Piqueras-Fiszman 2016). Therefore, ther might have a correlation between oral somatosensation and food preferences, subsequently influencing eating behavior and food consumption. A standard method, using a so-called Von Frey Hair monofilament, to assess tactile sensation was developed by Etter et al. (Etter, N. M et al.,. J. Vis. Exp. 2020) but has so far been only minimally used in Ear, Nose and Throat (ENT) cancer (Bearelly, Wang, \& Cheung, 2017; Bodin, Jäghagen, \& Isberg, 2004; Elfring, Boliek, Seikaly, Harris, \& Rieger, 2012). The aim of the study is to determine the variability and role of somatosensory perception (texture, pungency transmitted through the trigeminal system, and temperature) on food preferences in cancer patients compared to healthy volunteers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

March 10, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

May 20, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 14, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2023

Completed
Last Updated

September 9, 2025

Status Verified

September 1, 2025

Enrollment Period

11 months

First QC Date

February 14, 2022

Last Update Submit

September 2, 2025

Conditions

Keywords

Head and Neck cancersnutritionsomesthesia

Outcome Measures

Primary Outcomes (1)

  • Oral tactile sensitivity score

    The primary endpoint of the study is to measure oral tactile sensitivity using the Von Frey Hair monofilament pressure test in head and neck cancer patients compared to healthy volunteers. This will be assessed at recruitment for healthy volunteers and between 1 to 3 months after recruitment for head and neck cancer patients.

    Up to 3 months after recruitment.

Secondary Outcomes (7)

  • thermic sensitivity score

    Up to 3 months after recruitment.

  • trigeminal sensitivity score

    Up to 3 months after inclusion.

  • texture sensitivity score

    Up to 3 months after recruitment.

  • salivary function

    Up to 3 months after recruitment.

  • food preference score

    Up to 3 months after recruitment.

  • +2 more secondary outcomes

Study Arms (3)

head and neck cancer patients with radiotherapy AND chemotherapy

EXPERIMENTAL

patients included for a head and neck cancer and treated by radiotherapy (+/- surgery) + chemotherapy

Other: Sensorial testsBehavioral: food preferences questionnaires

head and neck cancer patients with radiotherapy only

EXPERIMENTAL

patients included for a head and neck cancer and treated by radiotherapy (+/- surgery) without chemotherapy

Other: Sensorial testsBehavioral: food preferences questionnaires

healthy volunteers

ACTIVE COMPARATOR

healthy volunteers paired with experimental patients on age (+/- 5 years), gender, tobacco status

Other: Sensorial testsBehavioral: food preferences questionnaires

Interventions

Patients will be included in the study between 3 to 6 months after the end of treatment and go to the Paul Bocuse Research Institute to perform several sensorial tests. The same sensorial tests will be completed by healthy volunteers to compare.

head and neck cancer patients with radiotherapy AND chemotherapyhead and neck cancer patients with radiotherapy onlyhealthy volunteers

Patients will be included in the study between 3 to 6 months after the end of treatment and go at Institut Paul Bocuse to complete food preferences questionnaires. The same questionnaires will be completed by healthy volunteers to compare.

head and neck cancer patients with radiotherapy AND chemotherapyhead and neck cancer patients with radiotherapy onlyhealthy volunteers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All subjects:
  • Person between 18 and 65 years
  • Person having given free, informed, express written consent
  • Person affiliated to a French social security system
  • Person with a body mass superior to 18 kg/m².
  • Person able to come once to the Institut Paul Bocuse
  • Patients with head and neck cancer with chemotherapy:
  • \- Patient diagnosed with squamous cell head and neck cancer with the following treatment regimen: Surgery + radiochemotherapy or radiochemotherapy alone
  • Patients with head and neck cancer without chemotherapy:
  • \- Patient diagnosed with squamous cell head and neck cancer with the following treatment regimen: Surgery + radiation therapy or radiation therapy alone
  • Healthy volunteers :
  • Volunteer who is +/- 5 years of age relative to the patient to whom they are matched.
  • Volunteer of the same sex as the patient to whom they are matched
  • Volunteer with the same smoking status as the patient to whom they are matched
  • Volunteer with no current treatment that may affect taste and smell perception

You may not qualify if:

  • All subjects:
  • Person with a known food allergy/intolerance (lactose or milk protein) or unable to consume dairy or solid products (e.g., chocolate milk pudding, chocolate jelly)
  • Person with a known allergy to chili (or capsaicin)
  • Person with diagnosed total ageusia
  • Person with diagnosed total anosmia
  • Person deprived of liberty or under guardianship or trusteeship.
  • Pregnant or breastfeeding woman
  • Person deprived of liberty by a judicial or administrative decision
  • Person under guardianship or protection of vulnerable adults
  • Person with trismus (reduced jaw opening or limited jaw range of motion)
  • A person who is unable to extend his or her tongue
  • Person who has had surgery on the mobile tongue and/or base of the tongue
  • Person unable to swallow soft foods
  • Person who has had or is suspected of having had Corona Virus Disease (COVID)-19 within the last 6 months.
  • Patients with head and neck cancer:
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre de recherche de l'Institut Paul Bocuse

Écully, 69131, France

Location

Service d'Oncologie médicale, Hôpital de la Croix-Rousse

Lyon, 69004, France

Location

Related Publications (1)

  • Riantiningtyas RR, Valenti A, Dougkas A, Bredie WLP, Kwiecien C, Bruyas A, Giboreau A, Carrouel F. Oral somatosensory alterations and salivary dysfunction in head and neck cancer patients. Support Care Cancer. 2023 Oct 13;31(12):627. doi: 10.1007/s00520-023-08086-7.

    PMID: 37828382BACKGROUND

MeSH Terms

Conditions

Head and Neck Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasms

Study Officials

  • Amandine BRUYAS

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2022

First Posted

March 10, 2022

Study Start

May 20, 2022

Primary Completion

April 14, 2023

Study Completion

April 14, 2023

Last Updated

September 9, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations